NO173319C - Anvendelse av et olefyrin for p}visning av tumorer - Google Patents

Anvendelse av et olefyrin for p}visning av tumorer

Info

Publication number
NO173319C
NO173319C NO861724A NO861724A NO173319C NO 173319 C NO173319 C NO 173319C NO 861724 A NO861724 A NO 861724A NO 861724 A NO861724 A NO 861724A NO 173319 C NO173319 C NO 173319C
Authority
NO
Norway
Prior art keywords
tumors
olephyrin
display
detection
treatment
Prior art date
Application number
NO861724A
Other languages
English (en)
Norwegian (no)
Other versions
NO861724L (no
NO173319B (no
Inventor
Jerry C Bommer
Bruce F Burnham
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of NO861724L publication Critical patent/NO861724L/no
Publication of NO173319B publication Critical patent/NO173319B/no
Publication of NO173319C publication Critical patent/NO173319C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO861724A 1985-04-30 1986-04-30 Anvendelse av et olefyrin for p}visning av tumorer NO173319C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72878685A 1985-04-30 1985-04-30

Publications (3)

Publication Number Publication Date
NO861724L NO861724L (no) 1986-10-31
NO173319B NO173319B (no) 1993-08-23
NO173319C true NO173319C (no) 1993-12-01

Family

ID=24928279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861724A NO173319C (no) 1985-04-30 1986-04-30 Anvendelse av et olefyrin for p}visning av tumorer

Country Status (8)

Country Link
EP (1) EP0210351B1 (de)
JP (1) JPH0764728B2 (de)
AT (1) ATE91625T1 (de)
AU (1) AU589957B2 (de)
CA (1) CA1291710C (de)
DE (1) DE3688721T2 (de)
DK (1) DK168690B1 (de)
NO (1) NO173319C (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
JPS63192718A (ja) * 1987-02-06 1988-08-10 Hamari Yakuhin Kogyo Kk 肝障害抑制剤
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
CN1222286C (zh) * 1994-05-13 2005-10-12 孟山都公司 过亚硝酸盐分解催化剂的应用方法及其药物组合物
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
PT1346059E (pt) 2000-11-29 2012-06-01 Pci Biotech As Internalização fotoquímica para distribuição de moléculas no citosol
EP1339862B1 (de) 2000-11-29 2014-01-08 PCI Biotech AS Photochemische internalisierung bei virus-vermittelter einführung von molekülen in das cytosol
WO2010126179A1 (ko) * 2009-04-29 2010-11-04 다이아텍코리아 주식회사 클로린 e6-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물
RU2537759C1 (ru) * 2013-07-12 2015-01-10 Евгений Валерьевич Жаров Способ фотодинамической терапии онкологических заболеваний
US9733187B2 (en) 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
RU2604388C2 (ru) * 2015-04-29 2016-12-10 Евгений Владимирович Давыдов Флуоресцентная диагностика злокачественного новообразования животного

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819644B2 (ja) 1975-03-13 1983-04-19 ウェルファイド株式会社 スイチユウボウオザイ
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS57185220A (en) * 1981-05-07 1982-11-15 Yakult Honsha Co Ltd Carcinostatic agent containing chlorophyll derivative as active component
JPS58981A (ja) * 1981-06-26 1983-01-06 Tama Seikagaku Kk 水溶性ポルフイリン誘導体
US4614190A (en) 1981-09-08 1986-09-30 Alexei Stanco Photoradiation method and arrangement
AU581840B2 (en) * 1982-09-27 1989-03-09 Health Research Inc. Porphyrin derivatives
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
DK197286A (da) 1987-01-23
DK197286D0 (da) 1986-04-30
NO861724L (no) 1986-10-31
NO173319B (no) 1993-08-23
ATE91625T1 (de) 1993-08-15
JPS625912A (ja) 1987-01-12
AU5689186A (en) 1986-11-06
DK168690B1 (da) 1994-05-24
EP0210351A3 (en) 1990-09-05
EP0210351B1 (de) 1993-07-21
AU589957B2 (en) 1989-10-26
JPH0764728B2 (ja) 1995-07-12
CA1291710C (en) 1991-11-05
DE3688721T2 (de) 1993-12-16
DE3688721D1 (de) 1993-08-26
EP0210351A2 (de) 1987-02-04

Similar Documents

Publication Publication Date Title
NO173319C (no) Anvendelse av et olefyrin for p}visning av tumorer
SE8101064L (sv) Topiska farmaceutiska preparat innehallande salter av alkankarbonsyror samt nya karbonsyrasalter och forfarande for framstellning derav
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO168303C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
NO874788L (no) Fremgangsmaate til fremstilling av kinolinkarboksylsyrer.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
IT1198238B (it) Composti ad attivita' antibiotica
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
NO171912C (no) Fremgangsmaate for fremstilling av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyreestere
NO169716C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske beta-laktam-karboksylsyrer
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
ATE65396T1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
DK681288A (da) Aenootropt terapeutisk laegemiddelae
SE8701110D0 (sv) Terapeutisk indikation for kend substansgrupp
DE3778873D1 (de) Derivate von vorstufen von carboxylsaeure-medikamenten.
SU681818A1 (ru) Эфиры α-триалкилсилоксикарбоновых кислот, проявляющие анальгетическую или пролонгирующую гексеналовый наркоз активность

Legal Events

Date Code Title Description
MK1K Patent expired